Marketing-authorisation holder · United States
Ingenus Pharms LLC
9 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DESIPRAMINE HYDROCHLORIDE100mg | 10mg | 150mg | 25mg | 50mg | 75mg · Tablet | Desipramine | United States | Marketed | 1987 |
| DICLOFENAC POTASSIUM25mg | 50mg · Tablet | Diclofenac | United States | Marketed | 1998 |
| ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE37.5mg; 20mg · Tablet | Hydralazine, Isosorbide dinitrate | United States | Marketed | 2022 |
| LEUCOVORIN CALCIUM100MG BASE/10ML (EQ 10MG BASE/ML) | 3MG BASE/ML (EQ 3MG BASE/ML) | 3MG BASE/ML (EQ 3MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG BASE/50ML (EQ 10MG BASE/ML) · Solution | Calcium folinate | United States | Marketed | 1952 |
| LEVOLEUCOVORIN CALCIUM175mg base/17.5ml (eq 10mg base/ml) | 250mg base/25ml (eq 10mg base/ml) · Solution | Levoleucovorin | United States | Marketed | 2015 |
| MESNA400mg · Tablet | Mesna | United States | Marketed | 2025 |
| MEXILETINE HYDROCHLORIDE150mg | 200mg | 250mg · Capsule | Mexiletine | United States | Marketed | 1995 |
| TRIAZOLAM0.125mg | 0.25mg · Tablet | Triazolam | United States | Marketed | 1994 |
| LIFITEGRAST5% · Solution/drops | Lifitegrast | United States | tentative | 2023 |